SCHEMBL29637890

SCHEMBL29637890

COC(=O)c1cc(C(C)(C)C)ccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.62
CA1 P00915 3/20 0.62
CA2 P00918 3/20 0.62
CA7 P43166 3/20 0.62
CA9 Q16790 3/20 0.62
CA14 Q9ULX7 3/20 0.62
HSP90AA1 P07900 1/20 0.55
HSP90AB1 P08238 1/20 0.55
ALDH1A1 P00352 2/20 0.52
HSD17B10 Q99714 2/20 0.52
HPGD P15428 1/20 0.52
ALOX15 P16050 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
LMNA P02545 2/20 0.52
TSHR P16473 1/20 0.52
PTGS2 P35354 1/20 0.51
PLG P00747 2/20 0.50
KLK1 P06870 2/20 0.50
KLK6 Q92876 2/20 0.50
KLKB1 P03952 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL648753 1.00 CA12 (0.62) CA12CA1CA2CA7CA9
SCHEMBL13609957 0.88 CA12 (0.61) CA12CA1CA2CA7CA9
SCHEMBL3157053 0.86 CA12 (0.62) CA12CA1CA2CA7CA9
SCHEMBL14168030 0.86 CA12 (0.62) CA12CA1CA2CA7CA9
SCHEMBL23645185 0.85 CFTR (0.51) CA12CA1CA2CA7CA9
SCHEMBL13280707 0.84 CFTR (0.64) CA12CA1CA2CA7CA9
SCHEMBL4397432 0.83 CA12 (0.65) CA12CA1CA2CA7CA9
SCHEMBL8081709 0.83 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL10744053 0.82 CA12 (0.46) CA12CA1CA2CA7CA9
SCHEMBL13609971 0.82 CA12 (0.54) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117924170-A Methods for preparing modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2024-04-26 CN disclosed
CN-111479804-B Methods for preparing modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-12-22 CN disclosed
EP-4259139-A1 METHODS OF TREATMENT FOR CYSTIC FIBROSIS Vertex Pharmaceuticals Incorporated (US) 2023-10-18 EP disclosed
CN-116829148-A Methods of treating cystic fibrosis 弗特克斯药品有限公司 2023-09-29 CN disclosed
WO-2022125826-A1 METHODS OF TREATMENT FOR CYSTIC FIBROSIS VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-06-16 WO disclosed